Friday, November 13, 2015 1:19:18 PM
Multiple Sclerosis:
Tecfidera (BIIB) TRx/NRx 8828/1971 -6.5%/-13.9% w/w.
Copaxone (TEVA) TIW TRx/NRx 10033/1873 -5.2%/-9.1% w/w.
Glatop (SDZ) TRx/NRx 724/231 -1.5%/-3.3% w/w.
TRx mkt share Tecfidera 18.3% Copaxone 20.8% and Glatopa 1.5%.
¦ HCV: Sovaldi (GILD) TRx/NRx 1800/675 -3%/+2% w/w. Harvoni (GILD)
TRx/NRx 6653/2617 -6%/-6% w/w. Viekira Pak (ABBV) 592/224 +3%/+1%.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM